Friday 6 November 2026
Export DXCM’s income statement to Excel — free account
DexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.
- Revenue
- +11.2%
- EPS
- 0.00%
- Free cash flow
- −52.9%
- Total debt
- +0.31%
Quarter to September 2026, against a year earlier
79.96
4.50
−5.33%
Follow DXCM
Alert me
DexCom, Inc. (DXCM) revenue by segment, product and region
Where the money comes from and where it goes
| United States | 3,335 | 71.53% |
|---|---|---|
| International | 1,327 | 28.47% |
| Gross margin | 60.10% | |
| Operating margin | 19.56% | |
| Pre-tax margin | 23.35% |
Revenue by region $m
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 3,335 71.53% | 2,890 71.65% | 2,625 72.48% | 2,142 73.61% | 1,849 75.53% | 1,510 78.35% | 1,162 78.69% | 818 79.33% | 596 82.98% | 498 86.78% | 347 86.42% | 224 86.50% |
| International | 1,327 28.47% | 1,143 28.35% | 997 27.52% | 768 26.39% | 599 24.47% | 417 21.65% | 315 21.31% | 213 20.67% | 122 17.02% | 76 13.22% | 55 13.58% | 35 13.50% |
| Revenue | 4,662 | 4,033 | 3,622 | 2,910 | 2,449 | 1,927 | 1,476 | 1,032 | 719 | 573 | 402 | 259 |